Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP836616.RAqdPrVMlAeAvFZBmD6nA-WkvsZGLRfzyO3b0pIZdSViU130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP836616.RAqdPrVMlAeAvFZBmD6nA-WkvsZGLRfzyO3b0pIZdSViU130_assertion type Assertion NP836616.RAqdPrVMlAeAvFZBmD6nA-WkvsZGLRfzyO3b0pIZdSViU130_head.
- NP836616.RAqdPrVMlAeAvFZBmD6nA-WkvsZGLRfzyO3b0pIZdSViU130_assertion description "[As an example, we predicted that RAD50 with TRF2 have prostate cancer specific interaction that turned out to be having validation from the literature.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP836616.RAqdPrVMlAeAvFZBmD6nA-WkvsZGLRfzyO3b0pIZdSViU130_provenance.
- NP836616.RAqdPrVMlAeAvFZBmD6nA-WkvsZGLRfzyO3b0pIZdSViU130_assertion evidence source_evidence_literature NP836616.RAqdPrVMlAeAvFZBmD6nA-WkvsZGLRfzyO3b0pIZdSViU130_provenance.
- NP836616.RAqdPrVMlAeAvFZBmD6nA-WkvsZGLRfzyO3b0pIZdSViU130_assertion SIO_000772 21777411 NP836616.RAqdPrVMlAeAvFZBmD6nA-WkvsZGLRfzyO3b0pIZdSViU130_provenance.
- NP836616.RAqdPrVMlAeAvFZBmD6nA-WkvsZGLRfzyO3b0pIZdSViU130_assertion wasDerivedFrom befree-20150227 NP836616.RAqdPrVMlAeAvFZBmD6nA-WkvsZGLRfzyO3b0pIZdSViU130_provenance.
- NP836616.RAqdPrVMlAeAvFZBmD6nA-WkvsZGLRfzyO3b0pIZdSViU130_assertion wasGeneratedBy ECO_0000203 NP836616.RAqdPrVMlAeAvFZBmD6nA-WkvsZGLRfzyO3b0pIZdSViU130_provenance.